Literature DB >> 24511479

Perindopril may improve the hippocampal reduced glutathione content in rats.

Tahereh Mashhoody1, Karim Rastegar1, Fatemeh Zal2.   

Abstract

PURPOSE: Oxidative stress and renin- angiotensin system are both involved in the pathophysiology of most of the systemic and central disorders as well as in aging. Angiotensin converting enzyme (ACE) inhibitors, well known for their cardiovascular beneficial effects, have also shown antioxidant properties in pathologic conditions. This study aimed to evaluate the central effect of ACE inhibitors on oxidative status under no pathologic condition.
METHODS: Adult male rats were divided into four groups of 9 rats each. Groups were treated orally by perindopril at the doses of 1, 2, 4 mg/kg/day or normal saline as the control for four consecutive weeks. At the end of the treatment period the reduced and oxidized glutathione (GSH and GSSG respectively) and malondialdehyde (MDA), the product of lipid peroxidation, were measured in the rats' hippocampus.
RESULTS: The GSH increased dose dependently and was significantly higher in the 2 mg/kg perindopril treated group than the control group (p<0.05) while the GSSG level remained unchanged. As a consequent, the ratio of GSH to GSSG increased significantly in a dose dependent manner. There was not any significant change in MDA.
CONCLUSION: This study demonstrated that ACE inhibition may cause an increase in GSH as an anti- oxidant defense in the hippocampus.

Entities:  

Keywords:  ACE inhibitor; Glutathione; Hippocampus; Perindopril; Rat

Year:  2013        PMID: 24511479      PMCID: PMC3915815          DOI: 10.5681/apb.2014.023

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  30 in total

Review 1.  Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species.

Authors:  R Dringen; J M Gutterer; J Hirrlinger
Journal:  Eur J Biochem       Date:  2000-08

2.  A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.

Authors:  M I Colado; E O'Shea; R Granados; A Misra; T K Murray; A R Green
Journal:  Br J Pharmacol       Date:  1997-06       Impact factor: 8.739

Review 3.  Antihypertensive treatments, cognitive decline, and dementia.

Authors:  Emmanuelle Duron; Olivier Hanon
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease.

Authors:  Koji Yamada; Shinichi Uchida; Syusuke Takahashi; Makoto Takayama; Yoshinori Nagata; Nobuyuki Suzuki; Shiro Shirakura; Tomoyuki Kanda
Journal:  Brain Res       Date:  2010-07-31       Impact factor: 3.252

Review 5.  NAD(P)H oxidase: role in cardiovascular biology and disease.

Authors:  K K Griendling; D Sorescu; M Ushio-Fukai
Journal:  Circ Res       Date:  2000-03-17       Impact factor: 17.367

Review 6.  Angiotensin receptor blockers: therapeutic targets and cardiovascular protection.

Authors:  Luis M Ruilope; Enrico Agabiti Rosei; George L Bakris; Giuseppe Mancia; Neil R Poulter; Stefano Taddei; Thomas Unger; Massimo Volpe; Bernard Waeber; Faiez Zannad
Journal:  Blood Press       Date:  2005       Impact factor: 2.835

7.  Effect of melatonin on ischemia reperfusion injury induced by middle cerebral artery occlusion in rats.

Authors:  K Sinha; M N Degaonkar; N R Jagannathan; Y K Gupta
Journal:  Eur J Pharmacol       Date:  2001-10-05       Impact factor: 4.432

Review 8.  Oxidative stress and its role in the pathogenesis of ischaemic stroke.

Authors:  C L Allen; U Bayraktutan
Journal:  Int J Stroke       Date:  2009-12       Impact factor: 5.266

9.  Comparative free radical scavenging action of angiotensin-converting enzyme inhibitors with and without the sulfhydryl radical.

Authors:  S Suzuki; H Sato; H Shimada; N Takashima; M Arakawa
Journal:  Pharmacology       Date:  1993-07       Impact factor: 2.547

Review 10.  Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury.

Authors:  Connie H Y Wong; Peter J Crack
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

View more
  10 in total

Review 1.  Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer's disease.

Authors:  Heeyoung Lee; EunYoung Kim
Journal:  Arch Pharm Res       Date:  2020-09-09       Impact factor: 4.946

2.  Potential mechanisms underlying the association between type II diabetes mellitus and cognitive dysfunction in rats: a link between miRNA-21 and Resveratrol's neuroprotective action.

Authors:  Norhan S El-Sayed; Soha Elatrebi; Rasha Said; Heba F Ibrahim; Eman M Omar
Journal:  Metab Brain Dis       Date:  2022-07-04       Impact factor: 3.655

3.  Glutathione-dependent enzymes in the follicular fluid of the first-retrieved oocyte and their impact on oocyte and embryos in polycystic ovary syndrome: A cross-sectional study.

Authors:  Fatemeh Zal; Pardis Ahmadi; Maryam Davari; Fatemeh Khademi; Mojgan Akbarzadeh Jahromi; Zahra Anvar; Bahia Namavar Jahromi
Journal:  Int J Reprod Biomed       Date:  2020-06-30

4.  Tempol and perindopril protect against lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative stress.

Authors:  Mohammed Ragab Abdel-Aziz Ali; Amira Morad Hussein Abo-Youssef; Basim Anwar Shehata Messiha; Mahmoud Mohamed Khattab
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-03-30       Impact factor: 3.000

5.  The Protective Effects of Perindopril Against Acute Kidney Damage Caused by Septic Shock.

Authors:  Ugur Kostakoglu; Tolga Mercantepe; Hulya Kilic Yilmaz; Levent Tumkaya; Sule Batcik; Esra Pinarbas; Huseyin Avni Uydu
Journal:  Inflammation       Date:  2021-02       Impact factor: 4.092

6.  Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study.

Authors:  Christopher D Verrico; Colin N Haile; Richard De La Garza; Kenneth Grasing; Thomas R Kosten; Thomas F Newton
Journal:  Int J Neuropsychopharmacol       Date:  2016-07-05       Impact factor: 5.176

7.  Effect of angiotensin-converting enzyme inhibitor, lisinopril on morphological and biochemical aspects of fibrotic liver regeneration.

Authors:  Aysha Ambreen; Sarwat Jahan; Satwat Malik
Journal:  Saudi J Gastroenterol       Date:  2016-11       Impact factor: 2.485

8.  Adaptive Response Induced by Pre-Exposure to 915 MHz Radiofrequency: A Possible Role for Antioxidant Enzyme Activity.

Authors:  S M J Mortazavi; Z Mostafavi-Pour; M Daneshmand; F Zal; R Zare; M A Mosleh-Shirazi
Journal:  J Biomed Phys Eng       Date:  2017-06-01

9.  Targeting AGEs Signaling Ameliorates Central Nervous System Diabetic Complications in Rats.

Authors:  Mohamed Naguib Zakaria; Hany M El-Bassossy; Waleed Barakat
Journal:  Adv Pharmacol Sci       Date:  2015-09-29

10.  Protective effects of quercetin against hyperglycemia-induced oxidative stress in hepatic HepG2 cell line.

Authors:  Amir Yarahmadi; Mostafa Moradi Sarabi; Ahmad Sayahi; Fatemeh Zal
Journal:  Avicenna J Phytomed       Date:  2021 May-Jun
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.